Solid Biosciences Inc at JMP Securities Life Sciences Conference Transcript
All right, welcome back. My name is Silvan Türkcan. I'm a senior analyst with JMP Securities, covering precision sciences. And it's my pleasure to introduce Bo Cumbo, CEO of Solid Biosciences. Thank you so much for joining us today.
Yeah. Thank you, Silvan. Thank you, JMP, for the invitation. Appreciate everybody coming to see the presentation today.
I'm going to be making a number of forward-looking statements, many of which are out of Solid's control. Please take time to read through the forward-looking statements before investing.
So this year -- if you have not been following Solid in the past, this year is going to be a year of transformation for the company in -- not just in one aspect, but really the entire company, from people, pipeline, process. As many of you know, Solid Biosciences bought a company called AavantiBio. And I recently came from AavantiBio to Solid Biosciences, brought with us the management team, pipeline, new processes.
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |